FAM225A and esophageal squamous cell carcinoma: Furthermore, Kaplan-Meier analysis showed that ESCC patients with higher lncRNA FAM225A expression had no statistic difference for overall survival (OS) (Figure 1E), while there was significant worse disease-free survival (DFS) in comparison with patients had low lncRNA FAM225A expression (Figure 1F).